Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion

Abstract

loading...

About

This paper, published in 1950, received 537 indexed citations. Written by Caroline Bonner, Julie Kerr‐Conte, Valéry Gmyr, Gurvan Quéniat, Ericka Moerman, Julien Thévenet, Nathalie Delalleau, Iuliana Popescu, Willy Malaisse and Abdullah Sener covering the research area of Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. It is primarily cited by scholars working on Endocrinology, Diabetes and Metabolism (481 citations), Surgery (358 citations) and Molecular Biology (214 citations). Published in Nature Medicine.

In The Last Decade

doi.org/10.1038/nm.3828 →

Countries where authors are citing Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion

Since Specialization
Citations

This map shows the geographic impact of Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion more than expected).

Fields of papers citing Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/nm.3828.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026